The CX5 series is a multifunctional nanozyme complex based on the platform technology of the CX series. Complex symptoms can be effectively treated by introducing additional biological response modifiers, while retaining core nanozyme properties.
Versatility can be secured by combining the characteristics of nanozymes, which can effectively scavenge various reactive oxygen species, and other active materials that can be used to simultaneously treat various pathologies.
Nanozyme complex is a technology based on the CX platform, and developed under a synthetic platform equivalent to nanozyme. CX platform technology possesses high scalability, suitable for producing multi-functional complexes.
The CX platform includes technologies with customizable biocompatible polymer coatings for use in a variety of environments. This provides a variety of options to ensure optimal stability, tailored to the specific characteristics of the clinical application.